Pall Corporation, one of the leading  providers of cutting-edge products and services to meet the demanding needs of customers discovering, developing and producing biotechnology drugs, vaccines and classic pharmaceuticals, has introduced  Pall Acrodisc MS syringe filter, the first syringe filter certified for low extractables in high performance liquid chromatography/mass spectrometry (LCMS) applications. This is designed specifically for LCMS application. The Acrodisc MS syringe filter improves the accuracy of testing, enhances LCMS performance and extends the longevity of testing instrumentation.
 
The low extractable levels of the new Acrodisc MS syringe filter minimize interference with the ionization process and reduce the need for retesting. This lowers costs while minimizing downtime due to unexpected contamination. To ensure high performance, product tubes are packaged individually so that filters not currently in use remain sealed and protected from external contamination.

Constructed with Pall’s new WWPTFE membrane in a high density polyethylene housing, the Acrodisc MS syringe filter can be used with both organic and aqueous solvents. It offers excellent chemical resistance, good particulate retention, and minimal protein adsorption. This protects instrument columns from particulate build-up and reduces the frequency and cost of replacement. It also enables more consistent LCMS testing performance.

“Pall’s Acrodisc MS syringe filter is the newest innovation in our comprehensive line of syringe filters and the first LCMS-certified syringe filter that is low in extractables,” said Larry O’Connell, senior vice president, Pall Global Lab Products. “It will improve the accuracy, cost, and reliability of high performance LCMS testing and the applications for this advancement are extensive”, he added.